APAlexandr Pavlov

Alexandr Pavlov

*This is an algorithmically generated author record based on publicly available information.

Alexandr Pavlov has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ischemic stroke in a patient with floating thrombosis of the left ventricular aneurysm and complete atrioventricular block infected with a COVID-19: a case report

    by T. A. Pavlenko, A. V. Pavlov, A. Yu. Lebedeva

    Left ventricular (LV) thrombosis is a common complication of heart failure with reduced LV ejection fraction and can be a source of systemic embolism. The material presents the case of a 76-year-old woman with a history of myocardial infarction, LV aneurysm, coronary bypass surgery, who was admitted to the hospital with ischemic vertebrobasilar stroke. One month prior to present hospitalization, the patient was admitted to the hospital with transient complete atrioventricular block, underwent coronary artery stenting for stable angina pectoris with a drug-eluting stent, and was subsequently diagnosed with coronavirus disease 2019 (COVID-19), which required further inpatient treatment. Despite dual antithrombotic therapy (antiplatelet+anticoagulant) taken after discharge from the hospital, the patient was diagnosed with a floating thrombus in the apical LV aneurysm. Recurrent conduction disorders (transient atrioventricular block) required temporary pacing until the thrombus elements floated, after which a dual-chamber pacemaker was implanted. The main feature of this case is the formation of a floating thrombus in the LV aneurysm 11 years after myocardial infarction against the background of COVID-19 and anticoagulant therapy with direct oral anticoagulants. At the moment, there is still no unique opinion on the choice of anticoagulant therapy in patients with COVID-19 and a complicated cardiovascular history. In such cases, the anticoagulant regimen should be determined by a multidisciplinary team, taking into account the risks of thrombosis and bleeding.


  • Open Access

    ASSOCIATION OF LEFT ATRIAL FIBROSIS EXTENT WITH LEFT VENTRICULAR STRUCTURAL AND FUNCTIONAL REMODELLING IN PATIENTS WITH ATRIAL FIBRILLATION

    by T. P. Gizatulina, A. V. Pavlov, L. U. Martyanova, I. V. Shorokhova, G. V. Kolunin

    Aim.To investigate the relationships between left atrial (LA) fibrosis extent and left ventricular (LV) structural and functional status in patients (pts) with nonvalvular atrial fibrillation (AF).Material and Methods.The study enrolled 56 pts (mean age 57.1±8.4 years, 25 females), admitted to hospital for primary catheter ablation (CA), including 47 pts with paroxysmal AF and 9 pts with persistent AF. All pts had scheduled transthoracic echocardiography to measure size and volume of cardiac chambers and systolic and diastolic functions of the left ventricle. Based on the calculation of the LV mass index (LVMI) and relative wall thickness (RWT), we categorized all pts into 4 groups: (1) normal geometry (n=27); (2) concentric remodeling (normal LVMI and high RWT, n=13); (3) concentric hypertrophy (high LVMI and high RWT, n=6); and (4) eccentric remodeling (high LVMI and normal RWT, n=10). The assessment of LA fibrosis sizes was based on the allocation of low voltage zones (Results.Results of the study confirmed positive relationships between Sf, Sf% and LA diameter, LVMI, and NT-proBNP level. Negative relationship was noted between Sf, Sf%, the UTAH degree and LVEF. Such LV geometry type as eccentric hypertrophy was associated with a higher number of LA fibrosis zones compared to the normal LV geometry, while significant differences in other types of geometry were not found.Conclusion. Thus, LA fibrosis extent was associated with LA size, LV function, and LV geometric remodeling pattern.

  • Open Access

    P296Cryoablation of premature ventricular complexes arising from the septal region

    by G V Kolunin, V A Kuznetsov, V E Kharats, A V Pavlov, D V Belonogov, A L Ulyanov, A Y Rychkov, N Y Khorkova

    Background: With the introduction of catheter technologies into clinical practice, possibility of radical substrate elimination of different arrhythmias has appeared. Radiofrequency ablation (RFA) has shown its high efficiency, however in certain critical zones (in particular - paraseptal) it is associated with a risk of damage to the conduction system. In this regard, endovascular cryoablation, due to its exceptional properties, has become an alternative to RFA in a number of clinical situations.

  • P1182Acute release of natriuretic peptides in atrial fibrillation is independent of left atrial hemodynamics

    by M Sramko, D Wichterle, A Pavlov, T Gokdeniz, P Peichl, B Aldhoon, J Franekova, J Kautzner

    Funding Acknowledgements: This study was supported by the research grant of the Ministry of the Health of the Czech Republic - IKEM, IN 00023001

  • GW28-e0318 FACTORS ASSOCIATED WITH SUPER-RESPONSE TO CARDIAC RESYNCHRONISATION THERAPY

    by Anna Soldatova, Vadim Kuznetsov, Dmitrii Krinochkin, Tatyana Enina, Alexandr Pavlov

  • Open Access

    Steam, methane and carbon dioxide thermal plasma interaction with perhalocarbons

    by A V Surov, S D Popov, V E Popov, D I Subbotin, N V Obraztsov, J A Kuchina, E O Serba, Gh V Nakonechny, V A Spodobin, A V Pavlov, et al.

    Many perhalogenated hydrocarbons (including carbon tetrafluoride and carbon tetrachloride) are limited in production, because they have negative impact on the environment. A number of plasma technologies for perhalogenated hydrocarbons processing is proposed in addition to chemical methods. Usage of thermal plasma of methane and steam may be effective for the processing of these materials into carbon monoxide and certain hydrogen halide. The first stage of the investigation shows that hydrogen chloride is the only chlorine-containing compound during carbon tetrachloride processing.


    • 1 January 2012
      • Vol. 52  (4) , 38-48

    [Cryoballoon ablation for pulmonary vein isolation to treat atrial fibrillation: first experience in Russian Federation].

    by D S Lebedev, E N Mikhaĭlov, V S Orshanskaia, G V Kolunin, V E Kharats, A V Pavlov, V A Kuznetsov, E V Shliakhto

    Cryoballon ablation (CBA) for pulmonary vein (PV) isolation is a new method for catheter-based treatment of patients with atrial fibrillation (AF). The purpose of our work is to describe the CBA technique and to report its short-term results. Methods. CBA was performed in 12 patients (8 men; age 53.1+/-5.7 years) with highly symptomatic drug-refractory AF. Paroxysmal AF was present in 11 and persistent AF - in 1 patient. CBA procedure was carried out under general anesthesia with intubation in 6 and under light sedation in 6 patients. After transseptal access and direct PV angiography, 28 mm-cryoballoon was introduced into the left atrium, and more or equal 2 cryoapplications were delivered to each PV, once good PV occlusion was obtained. PV isolation was verified utilizing a circular mapping catheter. Arrhythmia recurrences were monitored every 3 months after ablation using 24-hour Holter, and additional ECG registrations. Holter monitoring was also performed in a case of symptoms. Results. Complete electrical PV isolation was achieved by only cryoballoon ablation in 11 patients, and additional cryocatheter touch-up ablation was required in left PVs in 1 patient. Total procedure time was 203.1+/-34.2 min, fluoroscopy time - 50.5+/-14.0 min. There were no complications. During a mean follow-up period of 136.8+/-59.8 days 9 (75%) patients were free from arrhythmia recurrence after a single procedure. Redo ablation was required in 1 patient, in whom electrical reconnection to all PVs was documented. Conclusion. CBA is a novel promising technique for treatment of patients with AF, and now is available in Russian Federation. The method standardizes and facilitates interventional AF treatment with acute isolation of 96% PVs. The short-term follow-up shows freedom from atrial tachyarrhythmias in 75% of patients.


    • 1 January 2012
      • Vol. 84  (8) , 52-6

    [Impact of cardiac resynchronization therapy on survival in patients with ischemic and nonischemic cardiomyopathy in clinical practice].

    by V A Kuznetzov, T O Vinogradova, T N Enina, G V Kolunin, V E Kharatz, A V Pavlov, D V Krinochkin, D V Belonogov, E A Gorbatenko, Iu A Efimova

    To compare the impact of cardiac resynchronization therapy (CRT) on survival in patients with ischemic and non-ischemic cardiomyopathy (CMP) in clinical practice. The study enrolled 206 patients with NYHA Functional Class II-IV chronic heart failure (CHF) and a left ventricular ejection fraction of < or = 35, including 107 patients implanted with CRT devices in combination with continuous drug therapy (DT). Among the 107 patients, 48 were diagnosed as having non-ischemic CMP (NCMP), 59 as coronary heart disease (CHD). The other 99 patients (12 with NCMP and 87 with CHD) were on DT only. Later on the patients from both groups were divided into subgroups according to the treatment policy of CHF: CRT + DT or DT only. The mean follow-up period was 24 +/- 18.1 months. The Kaplan-Meier survival analysis revealed that overall survival in the patients on CRT + DT was significantly higher than in those on DT (70 and 49%, respectively; p = 0.004). Analysis of the chosen treatment policy in the NCMP subgroup showed no significant differences in survival rates in the patients receiving CRT + DT or DT (74 versus 78%, respectively; p = 0.5). At the same time, the survival rates in the CHD patients on CRT + DT were significantly higher than those in the DT subgroup (68 versus 44%; p = 0.04). CRT significantly reduces overall mortality in patients with CHF in clinical practice. Our findings indicated that this effect was achieved mainly in patients with CHD, rather than in those with NCMP.

    • 1 January 2006
      • Vol. 78  (4) , 87-90

    [Echocardiography and selection of patients with chronic cardiac failure for cardiac resynchronizing therapy (review of literature and original results)].

    by V A Kuznetsov, D V Krinochkin, G V Kolukhin, V E Kharats, T Iu Gorbunova, A V Pavlov, D N Khomutinin

    • 1 January 2005
      • Vol. 45  (9) , 29-31

    [Effect of cardiac resynchronization therapy in the treatment of chronic heart failure].

    by V A Kuznetsov, G V Kolunin, V E Kharats, D V Krinochkin, T Iu Gorbunova, A V Pavlov, I P Zyrianov, E A Gorbatenko

    As a result of cardiac resynchronization therapy in all 10 patients with chronic NYHA class III-IV heart failure at duration of observation from 2 to 20 months was noted positive dynamics: improvement of self feeling, increase of 6 min walking distance, decrease of heart failure class, and improvement of functional parameters of the heart according to echocardiography data. Implantation of biventricular cardiac pacemaker to patients with chronic heart failure is relatively safe and accomplish-able from technical point of view. Cardiac resynchronization in patients with pronounced chronic heart failure appears to be an effective supplementation of drug therapy.